American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1646)
  6. Epidemiology and Biostatistics (1500)
  7. GSK Faculty (1390)
  8. Population Sciences Research Program (1385)
  9. Gastrointestinal Oncology Service (1358)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (82)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (51)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1646)
  6. Epidemiology and Biostatistics (1500)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (310)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (308)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8715)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (13)

More Publications

Results (9200)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of phase II trial of pegylated arginine deiminase (ADI-PEG20) in metastatic melanoma (MM)
    Meeting Abstract

    Feun, L. G.; You, M.; Wu, C.; Wangpaichitr, M.; Kuo, M. T.; Marini, A.; Jungbluth, A.; Savaraj, N.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Timing of failure of resected rectal cancer: What is the appropriate duration of postoperative imaging?
    Meeting Abstract

    Fischkoff, K.; Juan, J.; Saltz, L.; Riedel, E.; Weiser, M. R.; Nash, G.; Temple, L. K.; Paty, P.; Wong, W. D.; Guillem, J. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Comparison of in-dwelling catheters and talc pleurodesis in the management of malignant pleural effusions
    Meeting Abstract

    Demmy, T. L.; Gu, L.; Burkhalter, J. E.; Toloza, E. M.; D'Amico, T. A.; Sutherland, S.; Wang, X. F.; Archer, L.; Veit, L. J.; Kohman, L.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Phase I trial of pulse-dose vorinostat with flavopiridol in solid tumors
    Meeting Abstract

    Dickson, M. A.; Rathkopf, D. E.; Grant, S.; Roberts, J. D.; Reid, J. M.; Ames, M. M.; McGovern, R. M.; Gonen, M.; Dials, H. J.; Schwartz, G. K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A phase I study of NY-ESO-1 overlapping peptides with or without incomplete Freund's adjuvant and poly-ICLCL vaccination of ovarian cancer patients in second or third clinical remission
    Meeting Abstract

    Diefenbach, C. S. M.; Sabbatini, P.; Hensley, M. L.; Konner, J. A.; Tew, W. P.; Ritter, G.; Jungbluth, A.; Pan, L. S.; Old, L. J.; Gnjatic, S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Predictors of site-specific recurrence following combined modality therapy for locally advanced rectal cancer
    Meeting Abstract

    Ding, P.; Liska, D.; Goodman, K. A.; Saltz, L.; Guillem, J. G.; Paty, P.; Temple, L. K.; Nash, G. M.; Wong, W. D.; Weiser, M. R.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Validation study of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Meeting Abstract

    Dueck, A. C.; Mendoza, T. R.; Reeve, B. B.; Sloan, J. A.; Cleeland, C. S.; Hay, J.; Li, Y.; O'Mara, A. M.; Denicoff, A.; Basch, E. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of farletuzumab (MORAb-003) in combination with weekly paclitaxel in subjects with platinum-resistant or refractory relapsed ovarian cancer
    Meeting Abstract

    Elit, L.; Konner, J. A.; Armstrong, D. K.; Buck, M.; Dean, A.; Finkler, N. J.; Hulstine, A.; Schweizer, C.; Phillips, M.; Weil, S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Is the difference in reexcision rate of various margin assessment methods due solely to difference in volume excised?
    Meeting Abstract

    Culpepper, C. K.; Goldberg, J. I.; Choi, L.; Brogi, E.; Sclafani, L.; King, T. A.; Heerdt, A. S.; Reiner, A. S.; Patil, S.; Van Zee, K. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Impact of EGFR and KRAS mutations on survival in 1,000 patients with resected lung adenocarcinoma
    Meeting Abstract

    D'Angelo, S. P.; Janjigian, Y. Y.; Kris, M. G.; Pao, W.; Riely, G. J.; Marks, J.; Sima, C.; Dycoco, J.; Park, B. J.; Azzoli, C. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save